Sign inJoin waitlistJoin the waitlist

Douglas McNeel

Professor of Medicine · University of Wisconsin Hospitals and Clinics

Credentials: · · · ·

History

University of Wisconsin Hospitals and Clinics
Present

University of Washington Medical Center - Montlake
2000–2002
Fred Hutchinson Cancer Research Center
Internal Medicine
University of Washington School of Medicine
1997–2000
Internal Medicine
University of Chicago Medical Center
1994–1997
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1990–1994

Research

Role of B cells as antigen presenting cells
Review · Frontiers in Immunology · 2022 · Last of 6 authors · Corresponding · 281 citations
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Clinical Cancer Research · 2016 · 246 citations
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF
Cancer Research · 2009 · 217 citations

Glenn Liu
23 papers · 2 as a fellow
GW
George Wilding
13 papers
MD
Mary Disis
13 papers
Joshua Lang
11 papers · 7 as a fellow
HP
Hemanth Potluri
8 papers · 3 as a resident
Lawrence Fong
8 papers
CD
Charles Drake
7 papers
James Gulley
6 papers
Christos Kyriakopoulos
5 papers
Thomas Frye
5 papers · 2 as a resident
Emmanuel Antonarakis
4 papers
Ravi Madan
4 papers

Grants

University of Wisconsin Prostate SPORE
National Cancer Institute · P50
PI · $8.5M · University of Wisconsin-Madison
2023–2030
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Cancer Institute · P01
Project lead · $1.6M · University of Wisconsin-Madison
2020–2026
Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-Cell Activation
National Cancer Institute · R01
Contact PI · $1.7M · University of Wisconsin-Madison
2017–2022
Physician Scientist Training in Cancer Medicine
National Cancer Institute · T32
Contact PI · $2.2M · University of Wisconsin-Madison
1988–2016

Clinical trials

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Principal investigator · Recruiting · Phase 1
University of Wisconsin, Madison
2026–2030
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
University of Wisconsin, Madison
2019–2027
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
Principal investigator · Completed · Phase 1
University of Wisconsin, Madison
2015–2020
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Principal investigator · Completed · Phase 1, Phase 2
University of Wisconsin, Madison
2015–2023